June 22, 2026
From the Centers for Medicare & Medicaid Services (CMS) From CMS: §483.45(g) Labeling of Drugs and Biologicals and §483.45(h) Storage of Drugs and Biologicals: “ensure that all drugs and biologicals used in the facility are labeled in accordance with professional standards, including expiration dates.” It is good standard practice to date an ophthalmic (eye) medication…
February 4, 2026
An estimated 2 million older adults in the US have been taking benzodiazepines for more than 120 days1. Benzodiazepines are used for many conditions including anxiety, insomnia, seizures, muscle spasms, and panic disorders. Nonetheless, they are associated with several safety concerns. The 2023 AGS Beers Criteria for potentially inappropriate medication use in older adults states,…
April 16, 2024
From the Centers for Medicare & Medicaid Services (CMS) From CMS: §483.45(g) Labeling of Drugs and Biologicals and §483.45(h) Storage of Drugs and Biologicals: “ensure that all drugs and biologicals used in the facility are labeled in accordance with professional standards, including expiration dates.” It is good standard practice to date an ophthalmic (eye) medication…
March 26, 2024
What is Pharmacogenomics (PGx) testing? PGx is rapidly evolving science focused on how an individual’s genes may affect his or her response to medications. While many patients may metabolize a medication appropriately, others may metabolize it too quickly, too slowly, or not well at all. PGx testing identifies genetic variants that indicate potential drug-gene interactions…
Categories
